This technique allows researchers to insert, delete or modify DNA to silence, activate or otherwise modify an organism’s specific genetic characteristic. The technology can be used for the treatment of livestock diseases and cancer.
Genome editing, also known as gene editing or genome engineering, refers to various scientific techniques that enable changes to an organism’s DNA. At specific sites in the genome, these technologies allow for the addition, removal, or modification of genetic material. There are several genome editing techniques that have been developed. Among these techniques, CRISPR-Cas9, which stands for clustered regularly interspaced short palindromic repeats and CRISPR-associated protein 9, is more highly regarded for its greater precision and efficiency.
The potential to improve human health is enormous. It may alter DNA sequences that are sources of diseases, or help prevent genetic disorders. Genome editing is being explored to treat cancer, blood disorders, blindness, HIV/AIDS, cystic fibrosis, muscular dystrophy, Huntington’s disease and COVID-19, among others.
The African Union has formulated policies that create a continental strategic focus in harnessing biotechnology for socio-economic development, and whose key outcome is the “Freedom to Innovate” publication of 2007. Another such effort is the Science Technology & Innovation Strategy for Africa (STISA 2014-2024), with the formation of the Africa High Level Panel on Emerging Technologies (APET) for priority setting; one of whose priorities is the Gene Drives for Malaria Control and Elimination Strategy of 2018. AUDA also exercises leadership in supporting AU member states in international negotiations at the Convention on Biological Diversity Conference and Meeting of the Parties to the Biosafety Protocol (COP-MOP).
Further to these, through the Africa Biosafety Network of Expertise (ABNE), AUDA has made good progress in strengthening biosafety capacity in the region to ensure the safe and responsible use of these modern innovations. Moreover, in a move aimed at reinforcing the position of the genome editing agenda, the Africa Coalition for Communicating about Genome Editing was launched. It is a concept that was mooted and recommended during the Africa Biennial Biosciences Communication (ABBC2021) Symposium, held in South Africa.
Work on genome editing in Africa includes the mapping of gene sequences that are responsible for diseases specific to people of African descent, as well as building the technical capacity of Africans in this area of research.
African Computational Genomics Group
To identify the genes responsible for non-communicable diseases, the research group at the Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine, UK is analysing enormous amounts of genomic data. Their goal is to prevent and treat illness in which people of African descent are more susceptible.
Malaria Genomic Epidemiology Network (MalariaGEN)
MalariaGEN provides a data resource platform to help understand the genomic variation and evolution of mosquito populations in response to malaria intervention efforts such as insecticides. This knowledge would help guide the development of new tools for malaria control and elimination.
African Centre of Excellence for Genomics of Infectious Diseases (ACEGID)
Founded in 2014, the Nigerian-based ACEGID is producing African genomics scientists to close the skills gap on the continent, and contribute to the effective containment and control of highly infectious diseases such as Lassa fever, Ebola, and COVID-19.
Guidelines for Determining the Regulatory Process of Genome Edited Organisms and Products in Kenya
Kenya Office
6th Floor (Block A), Westcom Point Building
Mahiga Mairu Avenue, off Waiyaki Way
P.O. Box 14688-00800, Westlands-Nairobi, Kenya
Telephone: +254 20 4343 116 | +254 716 002 059
Email: info@afidep.org
Malawi Office
Petroda Glasshouse, Area 14 – plot number 14/191
P.O Box 31024, Lilongwe 3, Malawi
Telephone: +265 995 495 143
Email: info@afidep.org
© 2024 Health Tech Platform
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |